FERMENTA BIOTECH
Back to Balance Sheet
|
FERMENTA BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹29 Cr | ₹77 Cr | ₹97 Cr | ₹154 Cr | ₹131 Cr |
What is the latest Total Non-Current Liabilities ratio of FERMENTA BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹29 Cr |
| Mar2024 | ₹77 Cr |
| Mar2023 | ₹97 Cr |
| Mar2022 | ₹154 Cr |
| Mar2021 | ₹131 Cr |
How is Total Non-Current Liabilities of FERMENTA BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹29 Cr | -62.03 | |
| Mar2024 | ₹77 Cr | -20.94 | |
| Mar2023 | ₹97 Cr | -36.76 | |
| Mar2022 | ₹154 Cr | 17.22 | |
| Mar2021 | ₹131 Cr | - | |
Compare Total Non-Current Liabilities of peers of FERMENTA BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FERMENTA BIOTECH | ₹815.3 Cr | 1.1% | -9.7% | -11.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,287.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,657.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,202.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| CIPLA | ₹122,276.0 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,024.0 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
FERMENTA BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FERMENTA BIOTECH | 1.1% |
-9.7% |
-11.7% |
| SENSEX | -0.5% |
2% |
4.8% |
You may also like the below Video Courses